HomeStock ScreenerPhyto ChemFinancial Statements

Phyto Chem Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Phyto Chem (PHYTO) reported revenue ₹9 Cr, net profit ₹-2 Cr and EPS ₹-4.19, with a net profit margin of -22.2% and ROE of -40.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Phyto Chem stock price NSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -22.22% 2026 data
EBITDA Margin -22.22% 2026 data
Operating Margin -21.00% 2026 data
Return on Assets -7.14% 2026 data
Return on Equity -40.00% 2026 data

Balance Sheet Ratios

Current Ratio 25.00 2026 data
Equity Ratio 17.86% 2026 data
Asset Turnover 0.32 2026 data

PHYTO Revenue, Net Profit & EBITDA — Year-on-Year Growth

PHYTO YoY (March 2025 vs March 2026) — revenue -47.1%, net profit -100.0%, EBITDA -300.0%, expenses -26.7%. Review PHYTO earnings valuation to evaluate earnings-based valuation against sector peers.

Revenue Growth
-47.1%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-300.0%
Year-over-Year
Expense Growth
-26.7%
Year-over-Year
Equity Growth
-16.7%
Year-over-Year
Operating Cash Flow Growth
-33.3%
Year-over-Year

PHYTO Income Statement — Revenue, EBITDA & Net Profit

Phyto Chem revenue ₹9 Cr, EBITDA ₹-2 Cr, net profit ₹-2 Cr, EPS ₹-4.19 (2026) — net profit margin -22.2%. Explore PHYTO true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 9 17 17 27 24 45 46 60 61 47 24 44
Expenses 11 15 18 24 22 42 42 57 57 44 22 40
EBITDA -2 1 -1 3 3 3 3 3 4 3 2 3
Operating Profit Margin % -21.00% -10.00% -22.00% 10.00% 6.00% 5.00% 4.00% 4.00% 4.00% 6.00% 7.00% 6.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 2 2 2 2 2 2 3 2 2 2 2 2
Profit Before Tax -2 -1 -3 0 0 1 0 1 1 1 0 1
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit -2 -1 -3 0 0 1 0 1 1 1 0 1
Earnings Per Share (₹) -4.19 -2.31 -7.75 0.52 0.53 1.15 1.04 1.69 2.14 1.97 0.27 1.25

PHYTO Balance Sheet — Assets, Liabilities & Shareholders' Equity

PHYTO total assets ₹28 Cr, total equity ₹5 Cr, total liabilities ₹ Cr (2026) — ROE -40.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 28 28 32 40 39 45 68 73 58 42 30 36
Current Assets 25 25 28 36 34 41 62 68 53 38 25 31
Fixed Assets 2 2 3 3 3 3 5 4 4 3 4 4
Capital Work in Progress 0 0 0 0 0 0 0 1 0 0 0 0
Investments 8 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 25 29 37 35 42 63 68 53 39 26 32
LIABILITIES
Total Liabilities
Current Liabilities 1 2 3 4 4 5 4 4 4 2 3 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 5 6 7 11 11 10 10 9 9 8 8 8
Share Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 0 2 3 6 6 6 6 5 5 4 4 4

PHYTO Cash Flow Statement — Operating, Investing & Financing

Phyto Chem operating cash flow ₹2 Cr, investing ₹1 Cr, financing ₹-3 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 2 3 1 3 -1 2 3 1 2 0 -2
Investing Activities 1 0 0 0 1 0 -1 0 0 1 0
Financing Activities -3 -3 -2 -4 0 -1 -2 -1 -2 -1 2
Net Cash Flow 0 0 0 0 0 0 0 0 0 0 0